<DOC>
	<DOCNO>NCT02920801</DOCNO>
	<brief_summary>In study , investigator aim investigate whether saxagliptin modulate endothelial progenitor cell number flow-mediated dilation newly diagnose , treatment-naive type 2 diabetic patient .</brief_summary>
	<brief_title>Study About Effect Saxagliptin Circulating Endothelial Progenitor Cells Endothelial Function Newly Diagnosed Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>newly diagnose type 2 diabetic ( diagnosis make accord American Diabetes Association Guideline [ 19 ] ) , treatment naive , age 3075 , hemoglobin A1c ( HbA1c ) â‰¥6.5 % , fast cpeptide &gt; 1.0ng/L pregnancy lactation , smoker , acute disease infection , chronic renal disease ( estimate glomerular filtration rate &lt; 60 mL/min/1.73m2 ) , live enzymes 3 time normal range , positive islet autoantibody , fast cpeptide &lt; 1.0ng/L , severe hypertriglyceridemia ( triglyceride &gt; 5.6mmol/L ) , cardiovascular event surgery within 3 month , take glucocorticoid , history acute chronic pancreatitis , pancreatic tumor , severe cardiac pneumonic disease .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>saxagliptin</keyword>
	<keyword>endothelial progenitor cell</keyword>
	<keyword>flow-mediated dilation</keyword>
</DOC>